abc Technologies - Automation Beyond Chemistry
News Jan 30, 2007
Building on the success of the 2006 meeting, Chemspeed Technologies hosted their 7th annual abc Technologies (automation beyond chemistry) at the Basel Hilton, Switzerland last week, (25th – 26th January 2007). A select group of prominent scientists gathered for a provocative program of innovative process acceleration concepts from discovery to development.
The conference offered compelling topics and new perspectives on applications and emerging technologies for increasing efficiency and productivity in a broad range of industries, including pharmaceuticals, fine chemicals, polymers and catalysis.
The program addressed the complete R&D workflow, from early discovery to the final stage of process development.
Over 130 attendees enjoyed lectures from 14 leading experts from both academia and industry, viewed poster presentations, networked with colleagues and wandered around the small exhibition hall where a number of Chemspeed’s automation platforms were demonstrated.
The two day agenda covered topics including material sciences, medicinal chemistry and polymer R&D.
Plenary Speakers were:
• Prof. Allen Wright, University of Newcastle, U.K.
Towards the Automation of Reaction Mechanism Determination
• Prof. Joachim Kohn, New Jersey Center for Biomaterials, U.S.A.
Applications of Parallel Synthesis as Part of a New Discovery Paradigm or Biomaterials
• Prof. Ben Feringa, University of Groningen, The Netherlands
Exploring Chiral Space, from asymmetric catalysis to smart materials
• Prof. Dean Webster, North Dakota University, U.S.A.
High Throughput Methods for Discovery and Optimization in Protective Coatings Systems
• Prof. Nicola Pohl, Iowa State University, U.S.A.
Automated Fluorous-Phase Synthesis and Micro-Array Formulation
The meeting featured several poster presentations showing the latest research from both academia and industry. The award for the best poster presented at the meeting was sponsored Technology Networks (publishers of CombiChem.net, ProcessDevelopment.net, HighThroughputExperimentation.com and MicrowaveSynthesis.net)
The review board decided that the poster entitled “Towards the development of an Anti-cancer vaccine – Rational design of new Melan-A/Mart-1 Peptide Analogues” presented by Céline Douat-Casassus from Université Bordeaux was most deserving of the award.
Chemspeed Technologies will be holding the 2008 event at the Basel Hilton, January 16-17.
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE